Sigma Healthcare Withdraws $10 Billion Boots Bid as Australia M&A Failures Top $170 Billion
Updated
Updated · Bloomberg · Jun 16
Sigma Healthcare Withdraws $10 Billion Boots Bid as Australia M&A Failures Top $170 Billion
3 articles · Updated · Bloomberg · Jun 16
Summary
Sigma Healthcare’s exit from the Boots sale process ended a potential acquisition valued at about $10 billion, with the company saying it had ceased discussions immediately.
More than $170 billion of Australian outbound deals have been withdrawn or terminated over the past five years, making the failed Boots pursuit part of a broader pattern rather than a one-off setback.
Bankers have long targeted Australia for large Asia-Pacific transactions and their advisory fees, but local companies also tend to undervalue acquisition targets, according to Bloomberg’s report and analysis.
The collapse underscores the weak hit rate of Australian overseas dealmaking, highlighting persistent execution problems in one of the region’s most watched M&A markets.